Winston-Salem, NC, United States of America

Balwinder Singh Bhatti

This inventor holds 43 USPTO granted patents and 18 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Cholinergic Receptor Compounds. Top assignees: Targacept, Inc., Oyster Point Pharma, Inc., Catalyst Biosciences, Inc.. Active years: 1997-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Balwinder Singh Bhatti. Retrieved from https://idiyas.com/inventor/balwinder-singh-bhatti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 43 (Patent Applications = 18)

% Patents Active = 39.5

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 5.2

ph-index = 9

Forward Citations = 357(Granted Patents)

Location History:

Lexington, KY (US) (1997 - 1998)
Winstom-Salem, NC (US) (2020)
Winston-Salem, NC (US) (2000 - 2023)

Company Filing History:

Oyster Point Pharma, Inc.

patents

2 out of 26

Catalyst Biosciences, Inc.

patents

4. 4 out of 834,453

Other

patents

Years Active: 1997-2023

Loading Chart...

Areas of Expertise:

Cholinergic Receptors

Nicotinic Antagonists

Pharmaceutical Compositions

CNS Disorders

Synthesis Methods

Salt Forms

Neuronal Ligands

Pain Relief

Diazaspirocyclic Compounds

Azaspiroalkene Compounds

Dopamine Release

Activation Compounds

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11542253 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine (2023-01-03),

2. 10919879 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine (2021-02-16),

3. 10716770 - Nicotinic receptor non-competitive antagonists (2020-07-21),

4. 10421745 - Salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine (2019-09-24),

5. 10258582 - Nicotinic receptor non-competitive antagonists (2019-04-16),

6. 9981949 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine (2018-05-29),

7. 9532974 - Nicotinic receptor non-competitive antagonists (2017-01-03),

8. 9145396 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine (2015-09-29),

9. 8809397 - Nicotinic receptor non-competitive antagonists (2014-08-19),

10. 8802694 - 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetycholine receptor ligands (2014-08-12),

11. 8604191 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3YLVINYL)pyrimidine (2013-12-10),

12. 8288420 - Compounds capable of activating cholinergic receptors (2012-10-16),

13. 8153821 - Compounds (2012-04-10),

14. 7923559 - N-aryl diazaspirocyclic compounds and methods of preparation and use thereof (2011-04-12),

15. 7897611 - Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders (2011-03-01),

Title: **Balwinder Singh Bhatti: Innovator in Pharmaceutical Science**

Introduction

Balwinder Singh Bhatti is a prominent inventor based in Winston-Salem, NC, with an impressive portfolio of 43 patents. His work primarily focuses on the synthesis of novel chemical compounds, contributing significantly to the pharmaceutical industry.

Latest Patents

Among his latest contributions are patents related to the synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine. This invention details the stereospecific synthesis of this compound, along with its salt forms and novel polymorphic forms of these salts. The implications of such inventions are considerable, enhancing the development of new therapeutic agents.

Career Highlights

Bhatti has had a successful career working with notable companies, including Targacept, Inc. His expertise in chemical synthesis and pharmaceutical formulations has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Bhatti has collaborated with industry experts such as Gary Maurice Dull and Craig Harrison Miller. These partnerships have likely contributed to the breadth of his innovative work and patent portfolio.

Conclusion

Balwinder Singh Bhatti continues to make significant strides in the realm of pharmaceutical sciences. His commitment to innovation and the successful synthesis of complex compounds plays a vital role in advancing medical solutions. His numerous patents not only showcase his inventive spirit but also reflect the impact of his work on the industry.

Profile summary based on public USPTO records.